載入...
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
Current pharmacotherapy of Parkinson’s disease (PD) is symptomatic and palliative, with levodopa/carbidopa therapy remaining the prime treatment, and nevertheless, being unable to modulate the progression of the neurodegeneration. No available treatment for PD can enhance the patient’s life-quality...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504186/ https://ncbi.nlm.nih.gov/pubmed/32872273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21176235 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|